• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早发性结直肠癌患者中根据表型分类的致病性生殖系变异

Pathogenic germline variants in patients with early-onset colorectal cancer according to phenotype.

作者信息

Dardenne Antoine, Dhooge Marion, Basset Noémie, Chansavang Albain, Metras Julie, Farelly Solenne, Netter Jeanne, Coulet Florence, Benusiglio Patrick R

机构信息

Sorbonne Université, Service de Chirurgie digestive, Hôpital Saint-Antoine, APHP, Paris, France.

Paris Cité Université, Service de Gastroentérologie et Oncologie digestive, UF d'Oncogénétique digestive, Hôpital Cochin, APHP, Paris, France.

出版信息

Eur J Hum Genet. 2025 Mar 17. doi: 10.1038/s41431-025-01808-x.

DOI:10.1038/s41431-025-01808-x
PMID:40097831
Abstract

We assessed retrospectively the prevalence of pathogenic germline variants (PGV) in 268 French adult patients diagnosed with colorectal cancer (CRC) before age 41, stratified by phenotype. APC, BMPR1A, CDH1, EPCAM, MLH1, MSH2, MSH3, MSH6, MUTYH, NTHL1, POLE, POLD1, PTEN, PMS2, SMAD4, STK11 and TP53 were analyzed. Overall, 21.6% of cases carried a PGV. A high prevalence was observed in Mismatch Repair-deficient (MMRd) CRC (60.1%, MMR genes) and polyposis-associated CRC (48%, APC, MUTYH and MSH3-biallelic, POLE). Only 2.3% of patients with MMR proficient and without polyposis carried a PGV. The genes involved in this third group were POLE and MSH2, and three out of four cases had either two synchronous CRC or a CRC family history. Phenotypic features should be taken into account for testing decision. Evaluating the cost-effectiveness of testing all CRC cases < 41 years, as well as how it aligns with the constraints of various healthcare systems, is warranted.

摘要

我们对268例41岁之前被诊断为结直肠癌(CRC)的法国成年患者进行了回顾性评估,根据表型进行分层,分析了APC、BMPR1A、CDH1、EPCAM、MLH1、MSH2、MSH3、MSH6、MUTYH、NTHL1、POLE、POLD1、PTEN、PMS2、SMAD4、STK11和TP53等基因的致病种系变异(PGV)发生率。总体而言,21.6%的病例携带PGV。错配修复缺陷(MMRd)型CRC(60.1%,MMR基因)和息肉病相关CRC(48%,APC、MUTYH和MSH3双等位基因、POLE)中观察到高发生率。错配修复功能正常且无息肉病的患者中只有2.3%携带PGV。第三组涉及的基因是POLE和MSH2,四分之三的病例有两个同步发生的CRC或CRC家族史。检测决策应考虑表型特征。评估对所有41岁以下CRC病例进行检测的成本效益,以及其如何符合各种医疗保健系统的限制是有必要的。

相似文献

1
Pathogenic germline variants in patients with early-onset colorectal cancer according to phenotype.早发性结直肠癌患者中根据表型分类的致病性生殖系变异
Eur J Hum Genet. 2025 Mar 17. doi: 10.1038/s41431-025-01808-x.
2
Lynch Syndrome林奇综合征
3
Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancer.错配修复缺陷系统/微卫星高度不稳定型结直肠癌患者的第二原发性恶性肿瘤
Therap Adv Gastroenterol. 2025 Jun 21;18:17562848251347375. doi: 10.1177/17562848251347375. eCollection 2025.
4
MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma.MSH2、MSH6、MLH1和PMS2免疫组化作为小儿高级别胶质瘤中DNA错配修复缺陷综合征的高灵敏度筛查方法。
Acta Neuropathol. 2025 Feb 2;149(1):11. doi: 10.1007/s00401-025-02846-x.
5
PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer.PREMM5 可区分散发性和林奇综合征相关的 MMR 缺陷/MSI-H 结直肠癌。
Fam Cancer. 2023 Oct;22(4):459-465. doi: 10.1007/s10689-023-00345-0. Epub 2023 Aug 12.
6
Genetics, genomics and clinical features of adenomatous polyposis.腺瘤性息肉病的遗传学、基因组学及临床特征
Fam Cancer. 2025 Apr 16;24(2):38. doi: 10.1007/s10689-025-00460-0.
7
The Prevalence of Pathogenic or Likely Pathogenic Germline Variants in a Nationwide Cohort of Young Colorectal Cancer Patients Using a Panel of 18 Genes Associated with Colorectal Cancer.使用一组与结直肠癌相关的18个基因,对全国范围内的年轻结直肠癌患者队列进行致病性或可能致病性种系变异的患病率研究。
Cancers (Basel). 2021 Oct 12;13(20):5094. doi: 10.3390/cancers13205094.
8
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.在一项家庭与患者分析中对近期提出的结直肠癌易感基因变异进行验证——一项系统综述
Gastroenterology. 2017 Jan;152(1):75-77.e4. doi: 10.1053/j.gastro.2016.09.041. Epub 2016 Oct 3.
9
Chemoprevention of colorectal cancer: systematic review and economic evaluation.结直肠癌的化学预防:系统评价和经济评估。
Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.
10
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.结直肠癌患者林奇综合征的分子检测:系统评价和经济评估。
Health Technol Assess. 2017 Sep;21(51):1-238. doi: 10.3310/hta21510.

本文引用的文献

1
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.癌症患者种系基因检测面板的选择:ASCO 指南。
J Clin Oncol. 2024 Jul 20;42(21):2599-2615. doi: 10.1200/JCO.24.00662. Epub 2024 May 17.
2
Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).非转移性结肠癌:法国跨学科临床实践指南,用于诊断、治疗和随访(TNCD、SNFGE、FFCD、GERCOR、UNICANCER、SFCD、SFED、SFRO、ACHBT、SFP、AFEF 和 SFR)。
Dig Liver Dis. 2024 May;56(5):756-769. doi: 10.1016/j.dld.2024.01.208. Epub 2024 Feb 20.
3
A 39 kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing.
光学基因组图谱和纳米孔测序检测到导致林奇综合征的 39kb 结构性变异。
Eur J Hum Genet. 2024 May;32(5):513-520. doi: 10.1038/s41431-023-01494-7. Epub 2023 Nov 29.
4
Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants.超过 6000 名 CHEK2 致病性变异携带者的乳腺癌和结直肠癌风险:错义变异与截断变异的比较。
Cancer Genet. 2023 Nov;278-279:84-90. doi: 10.1016/j.cancergen.2023.10.002. Epub 2023 Oct 11.
5
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome.林奇综合征患者中错配修复功能完整的结直肠癌的流行情况及其临床意义。
JCO Precis Oncol. 2023 May;7:e2200675. doi: 10.1200/PO.22.00675.
6
Position statement of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) on I1307K and cancer risk.国际胃肠遗传肿瘤学会(InSiGHT)关于 I1307K 与癌症风险的立场声明。
J Med Genet. 2023 Nov;60(11):1035-1043. doi: 10.1136/jmg-2022-108984. Epub 2023 Apr 19.
7
Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer.多基因panel 检测在结直肠癌患者中能发现高比例的临床可操作变异。
JCO Precis Oncol. 2022 Nov;6:e2200517. doi: 10.1200/PO.22.00517.
8
Noncoding Aberrations in Mismatch Repair Genes Underlie a Substantial Part of the Missing Heritability in Lynch Syndrome.错配修复基因中的非编码畸变是林奇综合征中大部分遗传性缺失的基础。
Gastroenterology. 2022 Dec;163(6):1691-1694.e7. doi: 10.1053/j.gastro.2022.08.041. Epub 2022 Aug 28.
9
Germline Cancer Risk Profiles of Patients With Young-Onset Colorectal Cancer: Findings From a Prospective Universal Germline Testing and Telegenetics Program.青年起病型结直肠癌患者的胚系癌症风险概况:一项前瞻性通用胚系检测和远程遗传学项目的研究结果
Dis Colon Rectum. 2023 Apr 1;66(4):531-542. doi: 10.1097/DCR.0000000000002347. Epub 2022 Feb 21.
10
Germline and Tumor Sequencing as a Diagnostic Tool To Resolve Suspected Lynch Syndrome.胚系和肿瘤测序作为一种诊断工具,以解决疑似林奇综合征。
J Mol Diagn. 2021 Mar;23(3):358-371. doi: 10.1016/j.jmoldx.2020.12.003. Epub 2020 Dec 29.